Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2004-11-04
2009-12-29
Belyavskyi, Michail A (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388200, C424S142100, C424S143100
Reexamination Certificate
active
07638606
ABSTRACT:
The present invention relates to antibodies that bind to the IL-4 receptor, fragments, muteins, and derivatives of such antibodies, nucleic acids encoding such antibodies, fragments, muteins and derivatives, and methods of making and using such antibodies, fragments, muteins, derivatives and nucleic acids. Methods for treating medical conditions induced by interleukin-4 involve administering an IL-4 receptor binding antibody, or an IL-4 receptor binding fragment, mutein, or derivative of an IL-4 receptor binding antibody, to a patient afflicted with such a condition. Particular antibodies provided herein include human monoclonal antibodies. Certain of the antibodies inhibit both IL-4-induced and IL-13-induced biological activities.
REFERENCES:
patent: 5717072 (1998-02-01), Mosley et al.
patent: 6716587 (2004-04-01), Mosley et al.
patent: 0 604 693 (1994-07-01), None
patent: WO 90/05183 (1990-05-01), None
patent: WO 91/09059 (1991-06-01), None
patent: WO 94/21282 (1994-09-01), None
patent: WO 96/33735 (1996-10-01), None
patent: WO 96/34096 (1996-10-01), None
patent: WO 00/18932 (2000-04-01), None
patent: WO 01/92340 (2001-12-01), None
Hultgren O., et al., “Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth.”J. Immunol 1998:1605082-5087, May 1998.
Wills-Karp., et al., “Interleukin-13: Central Mediator of Allergic Asthma,”Science282:2258-2261, Dec. 1998.
Holt LJ, et al., “Domain antibodies: proteins for therapy,”Trends in Biotech, 21(11):484-490, Nov. 2003.
Zurawski SM, et al., “The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor,”J. Biol Chem270(23):13869-13878, Jun. 9, 1995.
Database EPOP: Accession No. AX356126, Feb. 15, 2002.
Related International Search Report for PCT/US01/17094.
Carter Paul J.
Zhou Hongxing
Belyavskyi Michail A
Immunex Corporation
Machin Nathan A.
Skelding Zachary
LandOfFree
Antibodies that bind interleukin-4 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies that bind interleukin-4 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies that bind interleukin-4 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4107163